As shown in Figure 3C,D, the number of infiltrated CD45+ and CD3+ cells in tumor tissues in the oHSV-4-1BBL treatment group increased significantly relative to that in the PBS and oHSV treatment groups. The gene discussed is PTPRC; the disease is neoplasm.